ANDA 40765, held by Amneal Pharms Ny. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 40765 (Extended Phenytoin Sodium), held by Amneal Pharms Ny, was first approved by FDA on Nov 12, 2008, with 11 approved supplements and 0 published complete response letters.
Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 12, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED · capsule;oral | Phenytoin Sodium | Rx |
| Aug 3, 2023 | Supplement 10Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 12Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 25Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 28Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 29Labeling · Standard review | Approved | None posted |
| Aug 3, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jan 3, 2014 | Supplement 5Labeling | Approved | None posted |
| Jan 3, 2014 | Supplement 8Labeling | Approved | None posted |
| Dec 31, 2013 | Supplement 4Labeling | Approved | None posted |
| Nov 12, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters